Reduced exercise capacity in systemic sclerosis patients without pulmonary involvement

References

• Lee P., Langevitz P., Busklia D. Mortality in systemic sclerosis (scleroderma). Arthritis Rheum 1980; 23: 581–90
   PubMedGoogle Scholar
• Beretta L., Caronni M., Origgi L., Ponti A., Santaniello A., Scorza R. Hormone replacement therapy may prevent the development of isolated pulmonary hypertension in patients with systemic sclerosis and limited cutaneous involvement. Scand J Rheum 2006; 35: 468–71
   PubMed Web of Science ®Google Scholar
• Souza R. B. C., Borges C. T. L., Takayama L., Aldrighi J. M., Pereira R. M. R. Systemic sclerosis and bone loss: the role of the disease and body composition. Scand J Rheum 2006; 35: 384–7
   PubMed Web of Science ®Google Scholar
• Sudduth C. D., Strange C., Cook W. R., Miller K. S., Baumann M., Collop N. A., et al. Failure of the circulatory system limits exercise performance in patients with systemic sclerosis. Am J Med 1993; 95: 413–18
   PubMed Web of Science ®Google Scholar
• Blom‐Bülow B., Jonson B., Bauer K. Factors limiting exercise performance in progressive systemic sclerosis. Semin Arthritis Rheum 1983; 2: 174–81
   Google Scholar
• Morelli S., Ferrante L., Sgreccia A., Eleuteri M. L., Perrone C., De Marzio P., et al. Pulmonary hypertension is associated with impaired exercise performance in patients with systemic sclerosis. Scand J Rheumatol 2000; 29: 236–42
   PubMedGoogle Scholar
• Schwaiblmair M., Behr J., Fruhmann G. Cardiorespiratory responses to incremental exercise in patients with systemic sclerosis. Chest 1996; 110: 1520–5
   PubMed Web of Science ®Google Scholar
• Subcommittee for Scleroderma Criteria of the American Rheumatism Association Diagnostic and Therapeutic Criteria Committee. Preliminary criteria for the classification of systemic sclerosis (scleroderma)., Arthritis Rheum. 23. 581–90
   Google Scholar
• Valentini G., Della Rossa A., Bombardieri S., Bencivelli W., Silman A. J., D'Angelo S., et al. European Scleroderma Study to define disease activity criteria for systemic sclerosis. II. Identification of disease activity variables and development of preliminary activity indexes. Ann Rheum Dis 2001; 592: 598–60
   Google Scholar
• Franklin B. A. Clinical exercise testing. ACSM's guideline for exercise testing and prescription, 6th edn., B. A Franklin, 2000; 91–114
   Google Scholar
• Alkotob M. L., Soltani P., Sheatt M. A., Katsetos M. C., Rothfield N., Hager W. D., et al. Reduced exercise capacity and stress induces pulmonary hypertension in patients with scleroderma. Chest 2006; 130: 176–81
   PubMed Web of Science ®Google Scholar
• Buch M. H., Denton C. P., Furst D. E., Guillevin L., Rubin L. J., Wells A. U., et al. Submaximal exercise testing in the assessment of interstitial lung disease secondary to systemic sclerosis: reproducibility and correlations of the 6‐min walk test. Ann Rheum Dis 2007; 66: 169–73
   PubMed Web of Science ®Google Scholar
• Buchfuhrer M. J., Hansen J. E., Robinson T. E., Sue D. Y., Wasserman K., Whipp B. J. Optimizing the exercise protocol for cardiopulmonary assessment. J Appl Physiol 1983; 55: 1558–64
   PubMed Web of Science ®Google Scholar
• Myers J., Buchanan N., Walsh D., Kraemer M., McAuley P., Hamilton‐Wessler M., et al. Comparison of the ramp versus standard exercise protocols. J Am Coll Cardiol 1991; 17: 1334–42
   PubMed Web of Science ®Google Scholar
• Hambrecht R., Schuler G. C., Muth T., Grunze M. F., Marburger C. T., Niebauer J., et al. Greater diagnostic sensitivity of treadmill versus cycle exercise testing of asymptomatic men with coronary artery disease. Am J Cardiol 1992; 70: 141–6
   PubMed Web of Science ®Google Scholar
• Eagle K. A., Berger P. B., Calkins H., Chaitman B. R., Ewy G. A., Fleishmann K. E., et al. ACC/AHA guideline update for perioperative cardiovascular evaluation for noncardiac surgery‐executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to update the 1996 Guidelines on Perioperative Cardiovascular Evaluation for Noncardiac Surgery). J Am Coll Cardiol 2002; 39: 542–53
   PubMed Web of Science ®Google Scholar
• Klippel J. H., Weyand C. M., Wortmann R. L. Systemic sclerosis and related syndromes. Primer on the rheumatic diseases, J. H Klippel, C. M Weyand, R. L Wortmann. Arthritis Foundation, Atlanta 1997; 263–75
   Google Scholar
• Hawkins S. A., Wiswell R. A. Rate and mechanism of maximal oxygen consumption decline with aging – implications for exercise training. Sports Med 2003; 33: 877–88
   PubMed Web of Science ®Google Scholar
• Blair S. N., Kampert J. B., Kohl H. W 3rd., Barlow C. E., Macera C. A., Paffenbarger R. S Jr., et al. Influences of cardiorespiratory fitness and other precursors on cardiovascular disease and all‐cause mortality in men and women. J Am Med Assoc 1996; 276: 205–10
   PubMed Web of Science ®Google Scholar